PFIZER INC Annual Income Tax Expense (Benefit) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pfizer Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Pfizer Inc Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$421M, a 47% increase year-over-year.
  • Pfizer Inc Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$28M, a 97.5% increase year-over-year.
  • Pfizer Inc annual Income Tax Expense (Benefit) for 2024 was -$28M, a 97.5% increase from 2023.
  • Pfizer Inc annual Income Tax Expense (Benefit) for 2023 was -$1.12B, a 134% decline from 2022.
  • Pfizer Inc annual Income Tax Expense (Benefit) for 2022 was $3.33B, a 79.7% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$28M +$1.09B +97.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$1.12B -$4.44B -134% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $3.33B +$1.48B +79.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $1.85B +$1.48B +401% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $370M -$213M -36.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $583M +$849M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$266M +$8.78B +97.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$9.05B -$10.2B -906% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $1.12B -$867M -43.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1.99B -$1.13B -36.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $3.12B -$1.19B -27.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $4.31B +$2.09B +93.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $2.22B -$1.4B -38.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $3.62B +$2.47B +214% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $1.15B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.